文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

COVID-19 大流行与非 COVID-19 危重患者短期结局的关联:巴西 ICU 观察性队列研究

The association of the COVID-19 pandemic and short-term outcomes of non-COVID-19 critically ill patients: an observational cohort study in Brazilian ICUs.
PubMed 文献 · Intensive Care Med · 2021-09-13
一句话结论2020 年巴西 165 个 ICU 中非 COVID-19 危重患者住院死亡率升至 6.4%,SMR 升高而资源使用不变,提示 ICU 绩效恶化。

该回顾性队列研究纳入 2011–2020 年巴西 165 个 ICU 的 644,644 例次入院,排除再入院和 COVID-19 患者后分析 514,219 例。2020 年非 COVID-19 患者年龄和 SAPS 3 略低,但住院死亡率 6.4%,高于 2019 年 5.6% 和 2018 年 6.1%。多变量混合回归显示 2020 年入院与 2016、2019 年相比死亡风险更高;各 ICU 的 SMR 在 2020 年升高而 SRU 不变,提示绩效恶化,扰动分析进一步证实结局变化。

要点

  • 2020 年非 COVID-19 危重患者住院死亡率 6.4%,高于 2019 年 5.6% 和 2018 年 6.1%,尽管年龄和 SAPS 3 略低。
  • 多变量混合回归(调整 SAPS 3,入院年份作固定效应和随机斜率)显示 2020 年入院与 2016、2019 年相比死亡风险更高。
  • 2020 年各 ICU 的标准化死亡比(SMR)升高而标准化资源使用(SRU)保持不变,提示 ICU 绩效恶化而非资源投入变化。
  • 可变寿命调整显示(VLAD)在 2020 年上升,随 COVID-19 病例数增加而开始下降,病例减少后趋势逆转,第二波时再次出现。
  • 扰动分析进一步证实非 COVID-19 危重患者 ICU 结局在 2020 年发生变化。

适用人群与场景

  • 2011–2020 年巴西 165 个 ICU 收治的成人危重患者,排除再入院和 COVID-19 患者后分析 514,219 例。
  • 原文未提及具体纳入/排除标准、急诊/院前场景或病情阶段。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:回顾性队列研究,纳入 165 个 ICU 网络,前瞻性收集 2011–2020 年入院信息,总入院 644,644 例,排除再入院和 COVID-19 后分析 514,219 例。
  • 2020 年非 COVID-19 患者年龄和 SAPS 3 略低,但住院死亡率 6.4%,高于 2019 年 5.6% 和 2018 年 6.1%。
  • 多变量混合回归(调整 SAPS 3,入院年份作固定效应和随机斜率)显示 2020 年入院与 2016、2019 年相比死亡风险更高。
  • 2020 年各 ICU 的 SMR 升高而 SRU 不变,提示绩效恶化;VLAD 在 2020 年上升,随 COVID-19 病例数增加而下降,病例减少后逆转,第二波再次出现。
  • 扰动分析进一步证实非 COVID-19 危重患者 ICU 结局变化。

证据类型、等级与局限

  • 证据类型:观察性回顾性队列研究。
  • 局限:回顾性设计,单国多中心网络,原文未提及混杂控制细节、数据完整性或前瞻性验证。

对床旁实践的改变

  • 提示在疫情高峰期应关注非 COVID-19 危重患者的救治质量,SMR 升高而 SRU 不变可能反映绩效下降而非资源不足。
  • 适用与不适用人群、常见陷阱原文未提及。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

PURPOSE: To assess whether intensive care unit (ICU) outcomes for patients not affected by coronavirus disease 2019 (COVID-19) worsened during the COVID-19 pandemic.

METHODS: Retrospective cohort study including prospectively collected information of patients admitted to 165 ICUs in a hospital network in Brazil between 2011 and 2020. Association between admission in 2020 and worse hospital outcomes was performed using different techniques, including assessment of changes in illness severity of admitted patients, a variable life-adjusted display of mortality during 2020, a multivariate mixed regression model with admission year as both fixed effect and random slope adjusted for SAPS 3 score, an analysis of trends in performance using standardized mortality ratio (SMR) and standardized resource use (SRU), and perturbation analysis.

RESULTS: A total of 644,644 admissions were considered. After excluding readmissions and patients with COVID-19, 514,219 patients were available for analysis. Non-COVID-19 patients admitted in 2020 had slightly lower age and SAPS 3 score but a higher mortality (6.4%) when compared with previous years (2019: 5.6%; 2018: 6.1%). Variable-adjusted life display (VLAD) in 2020 increased but started to decrease as the number of COVID-19 cases increased; this trend reversed as number of COVID cases reduced but recurred on the second wave. After logistic regression, being admitted in 2020 was associated with higher mortality when compared to previous years from 2016 and 2019. Individual ICUs standardized mortality ratio also increased during 2020 (higher SMR) while resource use remained constant, suggesting worsening performance. A perturbation analysis further confirmed changes in ICU outcomes for non-COVID-19 patients.

CONCLUSION: Hospital outcomes of non-COVID-19 critically ill patients worsened during the pandemic in 2020, possibly resulting in an increased number of deaths in critically ill non-COVID patients.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Zampieri FG, Bastos LSL, Soares M, et al. The association of the COVID-19 pandemic and short-term outcomes of non-COVID-19 critically ill patients: an observational cohort study in Brazilian ICUs. Intensive Care Med. 2021. PMID: 34518905. doi:10.1007/s00134-021-06528-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。